Kiran Mazumdar-Shaw is placing one of Biocon's biggest bets on a market many pharmaceutical companies are no longer prioritizing. As global drugmakers rush to capitalize on the booming demand for GLP-1 and obesity drugs, the Biocon...
India’s respiratory disease surge is creating massive demand for treatments, and pharma companies are moving fast to meet it.
Centre mandates doctor prescriptions for cough syrups and syrup-based medicines, ending OTC sales and strengthening drug safety regulations nationwide.
Knee arthritis is a disease that plagues millions of Indians, often carrying an unspoken sentence, that of eventual knee replacement.
Bajaj healthcare expansion is gaining momentum as Bajaj Integrated Health System (BIHS) joins hands with Philips India to strengthen connected healthcare delivery across the country.
The bowel disease treatment race is gaining momentum after Spyre Therapeutics reported positive results from a mid-stage clinical trial of its experimental ulcerative colitis drug, SPY002.
A Rs 500 crore AI healthcare hub is set to transform Telangana as Hyderabad-based Pulsus Group announced a major investment to expand its presence in the state's healthcare and technology ecosystem.
.jpeg "Copper-Based Drug Shows Promise in Alzheimer's Treatment")
A copper-based drug shows potential in reducing toxic proteins and improving cognition in Alzheimer’s, offering a new approach targeting brain waste clearance mechanisms.
India has gained access to a globally acclaimed prostate cancer therapy with the launch of Pluvicto by Novartis.The company announced the introduction of Pluvicto in India for eligible patients with advanced prostate cancer, marking...
HLL rolls out AMRIT Plus, a premium pharmacy chain as the government-owned healthcare company expands its presence in India's healthcare sector. HLL Lifecare has launched AMRIT Plus, a premium pharmacy chain designed to offer medicines, wellness...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")